LPL Financial
ABUS icon

LPL Financial’s Arbutus Biopharma ABUS Stock Holding History

LPL Financial’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,147
Closed -$37.5K – 5794
2025
Q2 		$37.5K Buy
12,147
+350
+3% +$1.16K ﹤0.01% 5400
2025
Q1 		$41.2K Sell
11,797
-550
-4% -$1.83K ﹤0.01% 5170
2024
Q4 		$40.4K Buy
12,347
+1,000
+9% +$3.68K ﹤0.01% 5128
2024
Q3 		$43.7K Buy
+11,347
New +$43.5K ﹤0.01% 5015
2021
Q4 		– Sell
-10,600
Closed -$45K – 4338
2021
Q3 		$45K Hold
10,600
– – ﹤0.01% 4234
2021
Q2 		$32K Hold
10,600
– – ﹤0.01% 4174
2021
Q1 		$35K Hold
10,600
– – ﹤0.01% 4020
2020
Q4 		$38K Buy
+10,600
New +$37.1K ﹤0.01% 3750

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial's ABUS Position: Q3 2025 in Review

LPL Financial sold out of Arbutus Biopharma (ABUS) in Q3 2025, closing a stake of 12,147 shares — an estimated $37.5K sold.

LPL Financial first reported a position in ABUS in Q4 2020 and held it in 8 quarters. The position peaked at $45K in Q3 2021. 166 funds tracked by Wall St. Rank hold ABUS as of Q3 2025.

  • LPL Financial reported no remaining Arbutus Biopharma position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 12,147 Arbutus Biopharma shares in Q3 2025, an estimated $37.5K.
  • LPL Financial first reported a position in Arbutus Biopharma in Q4 2020 and held it in 8 quarters.
  • LPL Financial's Arbutus Biopharma position peaked at $45K in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.